Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 501,313 | 496,304 | 392,604 | 353,829 | 308,770 |
| Marketable Securities | 322,092 | 331,487 | 338,465 | 328,157 | 308,076 |
| Receivables | 127,022 | 127,425 | 129,633 | 111,439 | 103,260 |
| Inventories | 42,646 | 40,475 | 37,632 | 31,041 | 29,942 |
| Income taxes - deferred | 10,642 | 14,006 | 10,103 | N/A | N/A |
| TOTAL | $1,019,741 | $1,024,602 | $925,650 | $841,347 | $766,798 |
| Non-Current Assets | |||||
| PPE Net | 153,582 | 150,776 | 148,871 | 150,388 | 151,070 |
| Investments And Advances | 193,485 | 128,066 | 133,113 | 138,807 | 148,472 |
| Other Non-Current Assets | 30,159 | 30,350 | 32,460 | 7,852 | 8,076 |
| TOTAL | $377,226 | $309,192 | $314,444 | $297,047 | $307,618 |
| Total Assets | $1,396,967 | $1,333,794 | $1,240,094 | $1,138,394 | $1,074,416 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,089 | 3,238 | 2,097 | 7,124 | 2,672 |
| Accrued Expenses | 101,913 | 97,933 | 87,473 | 78,155 | 75,455 |
| TOTAL | $107,802 | $102,942 | $91,268 | $86,896 | $79,489 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,436 | 11,292 | 10,950 | 10,851 | 10,253 |
| TOTAL | $12,436 | $11,292 | $10,950 | $10,851 | $10,253 |
| Total Liabilities | $120,238 | $114,234 | $102,218 | $97,747 | $89,742 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,480 | 29,232 | 28,998 | 28,943 | 28,899 |
| Retained earnings | 80,095 | 24,163 | -27,237 | -106,602 | -144,935 |
| Other shareholders' equity | -1,623 | 1,136 | 1,100 | 1,157 | 390 |
| TOTAL | $1,276,729 | $1,219,560 | $1,137,876 | $1,040,647 | $984,674 |
| Total Liabilities And Equity | $1,396,967 | $1,333,794 | $1,240,094 | $1,138,394 | $1,074,416 |